Can a One-Two punch tame overgrown wound tissue?

NCT ID NCT06681194

First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time

Summary

This trial tests three ways to treat hypergranulation tissue—excess flesh that can slow healing in traumatic wounds. Adults with non-infected wounds will receive either silver nitrate, triamcinolone, or both treatments in sequence. The goal is to see which approach best reduces the overgrown tissue and improves scar quality.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
silver nitrate, triamcinolone, or both in succession
What this could lead to
If successful, this could establish a standard treatment for hypergranulation tissue in traumatic wounds, improving healing and reducing scarring.
What could go wrong
This is a small, early-phase trial, so results may not apply broadly. Treatments may cause irritation or allergic reactions, and the combination approach might not outperform single agents.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GRANULATION TISSUE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • UPMC Mercy Hospital

    Pittsburgh, Pennsylvania, 15213, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.